Andrea E. Cavanna, MD PhD FRCP FANPA, is Consultant in Behavioural Neurology at the Department of Neuropsychiatry, National Centre for Mental Health, and Honorary Professor in Neuropsychiatry at Aston University, Birmingham (United Kingdom). He also works part-time for the University of Birmingham as Deputy Director of the MSc course in Clinical Neuropsychiatry. He has published extensively in the fields of behavioural neurology and neuropsychiatry, with special focus on the behavioural aspects of epilepsy and movement disorders. In 2010 he received the American Neuropsychiatric Association Career Development Award.

Select Guide Rating

• 1: Behavioural co-morbidities in epilepsy 2: Antiepileptic drugs and behaviour: Mechanisms of action 3: Carbamazepine, oxcarbazepine, and eslicarbazepine 4: Clonazepam and clobazam 5: Ethosuximide 6: Gabapentin 7: Lamotrigine 8: Levetiracetam, piracetam, and brivaracetam 9: Phenobarbital and primidone 10: Phenytoin 11: Pregabalin 12: Tiagabine 13: Topiramate 14: Valproate 15: Vigabatrin 16: Zonisamide 17: Other antiepileptic drugs: rufinamide, lacosamide, perampanel 18: Comparative evidence and clinical scenarios

Andrea E. Cavanna, MD PhD FRCP FANPA, is Consultant in Behavioural Neurology at the Department of Neuropsychiatry, National Centre for Mental Health, and Honorary Professor in Neuropsychiatry at Aston University, Birmingham (United Kingdom). He also works part-time for the University of Birmingham as Deputy Director of the MSc course in Clinical Neuropsychiatry. He has published extensively in the fields of behavioural neurology and neuropsychiatry, with special focus on the behavioural aspects of epilepsy and movement disorders. In 2010 he received the American Neuropsychiatric Association Career Development Award.

Select Guide Rating

• 1: Behavioural co-morbidities in epilepsy 2: Antiepileptic drugs and behaviour: Mechanisms of action 3: Carbamazepine, oxcarbazepine, and eslicarbazepine 4: Clonazepam and clobazam 5: Ethosuximide 6: Gabapentin 7: Lamotrigine 8: Levetiracetam, piracetam, and brivaracetam 9: Phenobarbital and primidone 10: Phenytoin 11: Pregabalin 12: Tiagabine 13: Topiramate 14: Valproate 15: Vigabatrin 16: Zonisamide 17: Other antiepileptic drugs: rufinamide, lacosamide, perampanel 18: Comparative evidence and clinical scenarios

Andrea E. Cavanna, MD PhD FRCP FANPA, is Consultant in Behavioural Neurology at the Department of Neuropsychiatry, National Centre for Mental Health, and Honorary Professor in Neuropsychiatry at Aston University, Birmingham (United Kingdom). He also works part-time for the University of Birmingham as Deputy Director of the MSc course in Clinical Neuropsychiatry. He has published extensively in the fields of behavioural neurology and neuropsychiatry, with special focus on the behavioural aspects of epilepsy and movement disorders. In 2010 he received the American Neuropsychiatric Association Career Development Award.

Select Guide Rating

• 1: Behavioural co-morbidities in epilepsy 2: Antiepileptic drugs and behaviour: Mechanisms of action 3: Carbamazepine, oxcarbazepine, and eslicarbazepine 4: Clonazepam and clobazam 5: Ethosuximide 6: Gabapentin 7: Lamotrigine 8: Levetiracetam, piracetam, and brivaracetam 9: Phenobarbital and primidone 10: Phenytoin 11: Pregabalin 12: Tiagabine 13: Topiramate 14: Valproate 15: Vigabatrin 16: Zonisamide 17: Other antiepileptic drugs: rufinamide, lacosamide, perampanel 18: Comparative evidence and clinical scenarios